triple agonist glp-1 A peptide of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss GLP-1 Medications for Weight Loss:
Description
2018, McLean et al
The use of semaglutide was associated with improved clinical symptoms, physical activity, exercise function, quality of life, and more significant weight loss than the placebo group
doi: 10.1016/j.oret.2024.05.003 [DOI] [PMC free article] [PubMed] [Google Scholar] 10.Hathaway JT, Shah MP, Hathaway DB, et al
It produces and metabolizes hormones, including estrogen and testosterone
